Dilantin vs keppra?

Here’s a practical comparison of Dilantin (phenytoin) vs Keppra (levetiracetam)—mainly in terms of uses, side effects, interactions, and what clinicians consider when choosing between them.

What they’re used for

• Dilantin (phenytoin): Commonly used for partial (focal) seizures and tonic-clonic seizures. Also used in some settings like status epilepticus (often in IV form).
• Keppra (levetiracetam): Used for focal seizures and generalized tonic-clonic seizures (and also other seizure types in some cases).

How they work (briefly)

• Phenytoin: Slows seizure activity by stabilizing neuronal membranes (blocks sodium channels).
  • It has nonlinear (“saturable”) metabolism, so small dose changes can cause big blood level changes.
• Levetiracetam: Binds to a synaptic protein (SV2A) and reduces seizure propagation.

Dosing and monitoring

• Dilantin: Usually requires blood level monitoring (therapeutic drug monitoring) because of variable metabolism and nonlinear kinetics. Dose adjustments often need serum levels.
• Keppra: No routine blood level monitoring in most patients. Dosing is more straightforward.

Drug interactions

• Dilantin: Many drug interactions (enzyme inducer—affects metabolism of many other meds). Interaction risk is a major reason clinicians prefer alternatives in many cases.
• Keppra: Fewer drug interactions overall.

Side effect profiles (key differences)

Dilantin (phenytoin)

Common/important:

• Gum overgrowth (gingival hyperplasia)
• Hirsutism (increased hair growth)
• Nausea, dizziness
• Sedation
• Coordination problems (ataxia), especially with higher levels
• Serious but less common: blood disorders, liver issues, rash (including rare severe rash)

Keppra (levetiracetam)

Common/important:

• Fatigue / sleepiness
• Dizziness
• Mood or behavior changes: irritability, agitation, anxiety, depression—this is one of the most notable reasons people stop or switch

Safety considerations

• Pregnancy: Both are used in epilepsy, but both have considerations. If pregnancy is possible, choice often depends on seizure type, history, and other meds, and clinicians may discuss risk-benefit and folic acid.
• Kidney disease: Keppra is cleared by the kidneys, so dose adjustments may be needed in renal impairment.
• Liver disease: Dilantin is metabolized in the liver, so it can be harder in significant hepatic impairment.

Which is “better”?

It depends on the person and the seizure type, but general patterns:

• Keppra is often favored for patients who need fewer interactions and don’t want blood level monitoring.
• Dilantin may be preferred in certain situations (e.g., specific seizure history, cost/availability, clinician experience), but it requires level monitoring and has more interaction risk.

If you tell me:

1. your (or the patient’s) seizure type,
2. age,
3. any other medications, and
4. whether there’s kidney/liver disease or mood issues,

…I can help you think through which one is typically a better fit and what to watch for.